INTECH Investment Management
IPSC icon

INTECH Investment Management’s Century Therapeutics IPSC Stock Holding History

INTECH Investment Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.8K Buy
+24,401
New +$55.7K ﹤0.01% 2033
2025
Q2 		– Sell
-35,814
Closed -$17K – 2568
2025
Q1 		$17K Buy
35,814
+12,922
+56% +$9.71K ﹤0.01% 2508
2024
Q4 		$23.1K Buy
+22,892
New +$31.2K ﹤0.01% 2369

Other funds holding IPSC

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

INTECH Investment Management's IPSC Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Century Therapeutics (IPSC) in Q2 2026: 24,401 shares worth $59.8K. The stake represents ﹤0.01% of the portfolio and ranks #2033 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in IPSC as recently as Q1 2025.

INTECH Investment Management first reported a position in IPSC in Q4 2024 and has held it in 3 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • INTECH Investment Management held 24,401 shares of Century Therapeutics worth $59.8K as of Q2 2026.
  • Century Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2033 holding.
  • INTECH Investment Management first reported a position in Century Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.